EEG resting-state gamma power as a potential biomarker of excitation / inhibition imbalance in autism: Evidence from the Autism Biomarkers Consortium for Clinical Trials.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
Come citare questo studio
Vardan Arutiunian, Catherine A Sugar, Adam Naples, Megha Santhosh, April R Levin, Heather Borland, Jessica Benton, Raphael A Bernier, Katarzyna Chawarska, Geraldine Dawson, James Dziura, Gerhard Hellemann, Susan Faja, Shafali Jeste, Natalia Kleinhans, Maura Sabatos-DeVito, Damla Şentürk, Frederic Shic, James C McPartland, Sara Jane Webb. (2026). EEG resting-state gamma power as a potential biomarker of excitation / inhibition imbalance in autism: Evidence from the Autism Biomarkers Consortium for Clinical Trials.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. DOI: 10.1016/j.euroneuro.2026.113864
Consulta la pubblicazione originale ↗